Evidence Hub

Thoracic aortic rupture in a patient with repeated oral fluoroquinolone administration

Narita M, Akasaka N, Shirakura K, Fukuta H, Nakatsu T, Kamiya H

Journal of surgical case reports, 2026

Abstract

Fluoroquinolones (FQs) are widely used antibiotics with a broad antibacterial spectrum. However, recent studies have raised concerns regarding the potential association of FQs with an increased risk of aortic aneurysm and aortic dissection. We report a case of an older patient with stable blood pressure and no aortic dilation who developed a thoracic aortic rupture following repeated FQ administration. Although a direct causal relationship between FQ exposure and aortic rupture remains unproven in this single case, this case suggests the need for careful monitoring for possible aortic events, particularly in older patients requiring repeated FQ therapy.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free